AUD 0.23
(6.98%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | - AUD | -100.0% |
2023 | 2.82 Million AUD | -16.48% |
2022 | 3.38 Million AUD | 57.98% |
2021 | 2.14 Million AUD | -33.03% |
2020 | 3.19 Million AUD | -26.48% |
2019 | 4.34 Million AUD | 33.38% |
2018 | 3.25 Million AUD | -1.47% |
2017 | 3.3 Million AUD | 21.7% |
2016 | 2.71 Million AUD | 14.62% |
2015 | 2.37 Million AUD | 22.27% |
2014 | 1.93 Million AUD | 13.4% |
2013 | 1.71 Million AUD | 5.71% |
2012 | 1.61 Million AUD | 4.21% |
2011 | 1.55 Million AUD | -5.39% |
2010 | 1.64 Million AUD | -6.54% |
2009 | 1.75 Million AUD | -37.18% |
2008 | 2.79 Million AUD | -60.81% |
2007 | 7.13 Million AUD | 16.79% |
2006 | 6.1 Million AUD | 90.16% |
2005 | 3.21 Million AUD | 947.73% |
2004 | 306.46 Thousand AUD | 350.87% |
2003 | 67.97 Thousand AUD | -89.97% |
2002 | 678 Thousand AUD | 0.0% |
2001 | - AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | - AUD | -100.0% |
2024 Q2 | 857.34 Thousand AUD | 0.0% |
2024 Q4 | - AUD | 0.0% |
2023 Q4 | 908.81 Thousand AUD | 0.0% |
2023 FY | 2.82 Million AUD | -16.48% |
2023 Q2 | 1.91 Million AUD | 0.0% |
2022 FY | 3.38 Million AUD | 57.98% |
2022 Q4 | 1.7 Million AUD | 0.0% |
2022 Q2 | 1.68 Million AUD | 0.0% |
2021 FY | 2.14 Million AUD | -33.03% |
2021 Q2 | 1.1 Million AUD | 0.0% |
2021 Q4 | 1.03 Million AUD | 0.0% |
2020 Q2 | 1.75 Million AUD | 0.0% |
2020 FY | 3.19 Million AUD | -26.48% |
2020 Q4 | 1.43 Million AUD | 0.0% |
2019 FY | 4.34 Million AUD | 33.38% |
2019 Q2 | 2.54 Million AUD | 0.0% |
2019 Q4 | 1.79 Million AUD | 0.0% |
2018 Q2 | 1.65 Million AUD | 0.0% |
2018 FY | 3.25 Million AUD | -1.47% |
2018 Q4 | 1.6 Million AUD | 0.0% |
2017 Q4 | 1.66 Million AUD | 0.0% |
2017 Q2 | 1.64 Million AUD | 0.0% |
2017 FY | 3.3 Million AUD | 21.7% |
2016 Q4 | 1.26 Million AUD | 0.0% |
2016 Q2 | 1.45 Million AUD | 0.0% |
2016 FY | 2.71 Million AUD | 14.62% |
2015 FY | 2.37 Million AUD | 22.27% |
2015 Q4 | 1.37 Million AUD | 0.0% |
2015 Q2 | 991.97 Thousand AUD | 0.0% |
2014 Q2 | 1.07 Million AUD | 152.18% |
2014 Q1 | 427.56 Thousand AUD | 0.0% |
2014 FY | 1.93 Million AUD | 13.4% |
2014 Q4 | 861.14 Thousand AUD | 0.0% |
2013 Q2 | 972.02 Thousand AUD | 140.33% |
2013 Q3 | 427.56 Thousand AUD | -56.01% |
2013 Q1 | 404.45 Thousand AUD | 0.0% |
2013 Q4 | 427.56 Thousand AUD | 0.0% |
2013 FY | 1.71 Million AUD | 5.71% |
2012 FY | 1.61 Million AUD | 4.21% |
2012 Q4 | 404.45 Thousand AUD | 0.0% |
2012 Q3 | 404.45 Thousand AUD | 0.0% |
2012 Q2 | 404.45 Thousand AUD | 4.21% |
2012 Q1 | 388.11 Thousand AUD | 0.0% |
2011 FY | 1.55 Million AUD | -5.39% |
2011 Q4 | 388.11 Thousand AUD | 0.0% |
2011 Q1 | 410.2 Thousand AUD | 0.0% |
2011 Q2 | 388.11 Thousand AUD | -5.39% |
2011 Q3 | 388.11 Thousand AUD | 0.0% |
2010 Q2 | 410.2 Thousand AUD | -6.54% |
2010 FY | 1.64 Million AUD | -6.54% |
2010 Q1 | 438.9 Thousand AUD | 0.0% |
2010 Q4 | 410.2 Thousand AUD | 0.0% |
2010 Q3 | 410.2 Thousand AUD | 0.0% |
2009 FY | 1.75 Million AUD | -37.18% |
2009 Q1 | 698.64 Thousand AUD | 0.0% |
2009 Q2 | 438.9 Thousand AUD | -37.18% |
2009 Q3 | 438.9 Thousand AUD | 0.0% |
2009 Q4 | 438.9 Thousand AUD | 0.0% |
2008 Q2 | 698.64 Thousand AUD | -39.05% |
2008 Q3 | 698.64 Thousand AUD | 0.0% |
2008 Q4 | 698.64 Thousand AUD | 0.0% |
2008 FY | 2.79 Million AUD | -60.81% |
2008 Q1 | 1.14 Million AUD | 0.0% |
2007 Q1 | 1.52 Million AUD | 0.0% |
2007 Q4 | 1.14 Million AUD | 0.0% |
2007 Q3 | 1.14 Million AUD | 0.0% |
2007 FY | 7.13 Million AUD | 16.79% |
2007 Q2 | 1.14 Million AUD | -24.9% |
2006 FY | 6.1 Million AUD | 90.16% |
2006 Q2 | 1.52 Million AUD | 88.84% |
2006 Q3 | 1.52 Million AUD | 0.0% |
2006 Q4 | 1.52 Million AUD | 0.0% |
2006 Q1 | 808.32 Thousand AUD | 0.0% |
2005 Q3 | 808.32 Thousand AUD | 0.0% |
2005 Q2 | 808.32 Thousand AUD | 823.45% |
2005 Q1 | 87.53 Thousand AUD | 0.0% |
2005 Q4 | 808.32 Thousand AUD | 0.0% |
2005 FY | 3.21 Million AUD | 947.73% |
2004 Q3 | 87.53 Thousand AUD | 0.0% |
2004 Q1 | 77.78 Thousand AUD | 0.0% |
2004 FY | 306.46 Thousand AUD | 350.87% |
2004 Q4 | 87.53 Thousand AUD | 0.0% |
2004 Q2 | 87.53 Thousand AUD | 12.53% |
2003 Q1 | 169.7 Thousand AUD | 0.0% |
2003 FY | 67.97 Thousand AUD | -89.97% |
2003 Q2 | 77.78 Thousand AUD | -54.16% |
2003 Q4 | 77.78 Thousand AUD | 0.0% |
2003 Q3 | 77.78 Thousand AUD | 0.0% |
2002 Q3 | 169.7 Thousand AUD | 0.0% |
2002 FY | 678 Thousand AUD | 0.0% |
2002 Q4 | 169.7 Thousand AUD | 0.0% |
2002 Q2 | 169.7 Thousand AUD | 0.0% |
2002 Q1 | - AUD | 0.0% |
2001 Q3 | - AUD | 0.0% |
2001 Q4 | - AUD | 0.0% |
2001 Q2 | - AUD | 0.0% |
2001 FY | - AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AdAlta Limited | 1.73 Million AUD | 100.0% |
Biome Australia Limited | 13 Million AUD | 100.0% |
Radiopharm Theranostics Limited | 299.22 Thousand AUD | 100.0% |
Biotron Limited | - AUD | NaN% |
Acrux Limited | 5.09 Million AUD | 100.0% |
Alterity Therapeutics Limited | 4.01 Million AUD | 100.0% |
Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 100.0% |
BTC Health Limited | 16.36 Thousand AUD | 100.0% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 100.0% |
CSL Limited | 22.41 Billion AUD | 100.0% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.0% |
Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 100.0% |
Immutep Limited | 3.5 Million AUD | 100.0% |
Memphasys Limited | 60 Thousand AUD | 100.0% |
Neuren Pharmaceuticals Limited | 231.92 Million AUD | 100.0% |
Noxopharm Limited | 2.4 Million AUD | 100.0% |
Prescient Therapeutics Limited | 3.71 Million AUD | 100.0% |
Race Oncology Limited | 4 Million AUD | 100.0% |
Starpharma Holdings Limited | 8.28 Million AUD | 100.0% |
Tissue Repair Ltd | 152.24 Thousand AUD | 100.0% |
EZZ Life Science Holdings Limited | 66.44 Million AUD | 100.0% |
Anatara Lifesciences Ltd | - AUD | NaN% |
Bio-Gene Technology Limited | 18.32 Thousand AUD | 100.0% |
Zelira Therapeutics Limited | 94.95 Thousand AUD | 100.0% |
Patrys Limited | 1.39 Million AUD | 100.0% |
Orthocell Limited | 5.31 Million AUD | 100.0% |
Imugene Limited | - AUD | NaN% |
PYC Therapeutics Limited | 22.05 Million AUD | 100.0% |
Proteomics International Laboratories Limited | 892.14 Thousand AUD | 100.0% |
Cynata Therapeutics Limited | 2.31 Million AUD | 100.0% |
Arovella Therapeutics Limited | 17 Thousand AUD | 100.0% |
Nanollose Limited | 12.5 Thousand AUD | 100.0% |
Invex Therapeutics Ltd | 1.21 Million AUD | 100.0% |
NeuroScientific Biopharmaceuticals Limited | - AUD | NaN% |
Amplia Therapeutics Limited | 4.45 Million AUD | 100.0% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 100.0% |
Nyrada Inc. | - AUD | NaN% |
Telix Pharmaceuticals Limited | 496.65 Million AUD | 100.0% |
Dimerix Limited | 583.47 Thousand AUD | 100.0% |
Hexima Limited | - AUD | NaN% |
AnteoTech Limited | 460.39 Thousand AUD | 100.0% |
Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 100.0% |
Recce Pharmaceuticals Ltd | - AUD | NaN% |
Avecho Biotechnology Limited | 473.55 Thousand AUD | 100.0% |
Actinogen Medical Limited | 9.93 Million AUD | 100.0% |
Immuron Limited | 4.9 Million AUD | 100.0% |
Argenica Therapeutics Limited | 2.59 Million AUD | 100.0% |